* Cardio Diagnostics Holdings Inc reported quarterly breakeven results per share for the quarter ended in December, higher than the same quarter last year, when the company reported EPS of -9 cents. The mean expectation of two analysts for the quarter was for a loss of 13 cents per share. Wall Street expected results to range from -14 cents to -13 cents per share.
* Revenue rose 458.9% to $5.31 thousand from a year ago; analysts expected $250.00 thousand.
* Cardio Diagnostics Holdings Inc's reported EPS for the quarter was breakeven results.
* The company reported a quarterly loss of $1.39 million.
* Cardio Diagnostics Holdings Inc shares had fallen by 2.1% this quarter and lost 44.2% so far this year.
FORECAST CHANGES
* The mean earnings estimate of analysts had risen by about 50% in the last three months.
* In the last 30 days, there have been no earnings estimate revisions by analysts covering the company.
RECOMMENDATIONS
* The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 2 "strong buy" or "buy," no "hold" and no "sell" or "strong sell."
* The average consensus recommendation for the biotechnology & medical research peer group is also "buy"
Wall Street's median 12-month price target for Cardio Diagnostics Holdings Inc is $6.00 This summary was machine generated from LSEG data April 2 at 05:26 p.m. UTC. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING ESTIMATE ACTUAL BEAT, MET,
MISSED
Dec. 31 2023 -0.13 0.00 Beat
Sep. 30 2023 -0.27 -0.16 Beat
Jun. 30 2023 -0.18 -0.39 Missed
Mar. 31 2023 -0.18 -0.11 Beat
Comments